Initial COVID-19 vaccine booster rollout will affect 3 percent of U.S. population, officials say
By
Alicia Lasek
Aug 13, 2021
The FDA is working with drugmakers Pfizer and Moderna to allow fully vaccinated immunocompromised people to receive an extra shot. Long-term care residents are not yet included in the booster campaign,...
Docs struggle with making MCI diagnoses, 2022 Alzheimer’s report finds
By
Alicia Lasek
Mar 23, 2022
Less than half of primary care physicians surveyed report being comfortable diagnosing mild cognitive impairment that’s due to Alzheimer’s disease. Fully 90% told researchers that it is “hard...
Show us the data: COVID vaccine boosters may get go-ahead, but LTC docs remain wary
By
Alicia Lasek
Danielle Brown
Aug 09, 2021
Booster shots for the most vulnerable appear to be on a fast track to federal authorization. But clinicians want information about necessity, safety, dosing and more to justify prescribing an extra dose...
U.S. may reduce 10-day isolation period in bid to keep healthcare workers on the job
By
Alicia Lasek
Dec 22, 2021
Healthcare facilities will need all hands on deck to respond to expected COVID-19 surges, and a shortened isolation period for those who test positive but are symptomless and fully vaccinated could help,...
Clinical briefs for Tuesday, Nov. 30
By
Alicia Lasek
Nov 30, 2021
‘Fully vaccinated’ may be moving target in face of breakthroughs, omicron … Merck’s COVID-19 pill effective, but less so than first shown, FDA finds … 3 more states join lawsuit challenging CMS...
Most senior living facilities short on coronavirus-fighting supplies, survey finds
By
Alicia Lasek
Mar 17, 2020
More than two-thirds of the nation’s senior living facilities report trouble sourcing equipment, particularly N95 respirators.
COVID vaccine protects elderly; delivery program has buy-in from nearly all U.S. nursing homes
By
Alicia Lasek
Nov 19, 2020
Fully 99% of skilled nursing facilities nationwide have signed on with the federal Pharmacy Partnership for Long-Term Care Program vaccine delivery initiative, HHS says. The news arrived just as Pfizer...
U.S. gives green light to Moderna’s COVID-19 vaccine
By
Alicia Lasek
Feb 01, 2022
“Spikevax” is the second COVID-19 mRNA vaccine to receive full FDA approval, following Pfizer-BioNTech’s Comirnaty in September.
Clinical briefs for Monday, Aug. 23
By
Alicia Lasek
Aug 23, 2021
FDA pushing to fully approve Pfizer COVID vaccine this week … Accessible strength training nearly equals effect of drugs in lowering blood pressure, experts find … Need for yearly COVID shot may not...
COVID shot boosters for all adults will help to reduce confusion, FDA says
By
Alicia Lasek
Nov 22, 2021
The FDA “heard loud and clear” that a simpler booster strategy was needed, its vaccine chief says. But the action may be too late to head off a winter virus surge, observers say.